Company profile: Apotheca Biosciences
1.1 - Company Overview
Company description
- Provider of cutting-edge medical products, nutraceuticals, and formulation and delivery technologies for the healthcare and consumer care industry, including transdermal, sublingual, and nasal delivery technologies for precise, controlled dosing of cannabinoids.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Apotheca Biosciences
Cellerix
HQ: Spain
Website
- Description: Provider of adult stem cell-based medicines and therapies for gastroenterology, dermatology, and immune-based diseases, including Cx401 for the treatment of complex perianal fistulas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellerix company profile →
Trevi Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical therapies for uremic pruritus and chronic cough, including Haduvio—an investigational oral nalbuphine ER therapy targeting the central and peripheral nervous systems for idiopathic pulmonary fibrosis (IPF)-related cough and refractory chronic cough (RCC).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trevi Therapeutics company profile →
Prismic Pharmaceuticals
HQ: United States
Website
- Description: Provider of novel prescription medical drugs for inflammatory diseases and prescription medical foods for the clinical dietary management of metabolic processes associated with disorders common in the aging 'baby boomer' population, including central nervous system disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prismic Pharmaceuticals company profile →
VivaBioCell
HQ: Italy
Website
- Description: Provider of innovative products leveraging proprietary cell culture and tissue engineering technologies for early diagnosis of autoimmune diseases (e.g., scleroderma, graft-versus-host disease) and treatment of oro-dental and maxillo-facial defects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VivaBioCell company profile →
Reata Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies for cancer, inflammation, neurodegenerative, renal, cardiovascular, and autoimmune diseases, including antioxidant and inflammation-modulating drugs and agents that correct protein misfolding. Offers Skyclarys (omaveloxolone), an FDA-approved treatment for Friedreich's Ataxia in patients 16+.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reata Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Apotheca Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Apotheca Biosciences
2.2 - Growth funds investing in similar companies to Apotheca Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Apotheca Biosciences
4.2 - Public trading comparable groups for Apotheca Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →